Celgene (CELG) Revenue and Net Income History

Historical revenue, operating income and net income for Celgene (CELG) over the last 10 years. The current TTM revenue for Celgene as of October 20, 2017 is $11.23B.

Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $94.923B $11.229B
Celgene Corp. is an independent biopharmaceutical company engaged primarily in the discovery, development and commercialization of orally administered, small molecule drugs for the treatment of cancer and immunological diseases.